Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,267
Closed -$215K 172
2023
Q1
$215K Hold
5,267
0.16% 144
2022
Q4
$270K Sell
5,267
-1,339
-20% -$64.2K 0.2% 124
2022
Q3
$289K Buy
6,606
+1,699
+35% +$82.6K 0.24% 116
2022
Q2
$257K Sell
4,907
-14
-0.3% -$713 0.2% 128
2022
Q1
$254K Sell
4,921
-90
-2% -$4.67K 0.17% 134
2021
Q4
$296K Hold
5,011
0.19% 130
2021
Q3
$215K Sell
5,011
-670
-12% -$29.7K 0.16% 152
2021
Q2
$222K Sell
5,681
-420
-7% -$16.3K 0.17% 147
2021
Q1
$221K Buy
6,101
+303
+5% +$10.8K 0.19% 135
2020
Q4
$213K Buy
+5,798
New +$213K 0.21% 122

Other funds holding PFE

Patron Partners's PFE Position: Q2 2023 in Review

Patron Partners sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,267 shares — an estimated $215K sold.

Patron Partners first reported a position in PFE in Q4 2020 and held it in 10 quarters. The position peaked at $296K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Patron Partners reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Patron Partners sold 5,267 Pfizer shares in Q2 2023, an estimated $215K.
  • Patron Partners first reported a position in Pfizer in Q4 2020 and held it in 10 quarters.
  • Patron Partners's Pfizer position peaked at $296K in Q4 2021.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Patron Partners's 13F filing for Q2 2023, filed 1 Aug 2023.